Skip to main content

Table 1 Baseline clinical and procedural characteristics of the patients who receiving intracoronary epinephrine

From: Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study

Characteristics

Rate

Gender (% male)

8 (67%)

Age (mean ± SD)

62 ± 12

Comorbid conditions

Diabetes Mellitus

2 (17%)

Hypertension

4 (33%)

Previous CABG

1 (8%)

Lesion location

Left anterior descending

4 (33%)

Circumflex

2 (17%)

Right coronary artery

6 (50%)

Preprocedural angiographic appearance of thrombus*

8 (67%)

TIMI flow grade before epinephrine

TIMI 1

8 (67%)

TIMI 2

4 (33%)

TIMI flow grade after epinephrine

TIMI 1

1 (8%)

TIMI 2

2 (17%)

TIMI 3

9 (75%)

TIMI frame count before epinephrine (mean ± SD)

56 ± 10

TIMI frame count after epinephrine (mean ± SD)

19 ± 11

  1. *Preprocedural thrombus was defined as discrete intraluminal filling defect, contrast staining, or haze in the target vessel or at the site of the target lesion.